In this webinar:
A novel cancer treatment that engineers our own immune cells to kill cancer.
Dr. Jim Whitlock explains Chimeric Antigen Receptor T-cell (CAR-T) therapy, and the emerging challenges and concerns related to its use within the scope of Childhood Acute Lymphoblastic Leukemia.
The webinar was followed by an interactive question and answer session.
The slide deck for this webinar is not available.
Originally broadcast on May 31st, 2018.